<DOC>
	<DOCNO>NCT02026336</DOCNO>
	<brief_summary>Patients persistent asthma different inflammatory phenotype . The electronic nose new technology capable distinguish volatile organic compound breath-prints exhale breath among different pulmonary disease . Question study . Is electronic nose breath-print analysis able discriminate among different inflammatory asthma phenotype ?</brief_summary>
	<brief_title>E-nose Inflammatory Asthma Phenotypes</brief_title>
	<detailed_description>Materials/patients method . Fifty-two consecutively enrol patient persistent asthma include cross-sectional proof concept study . Inflammatory asthma phenotype recognize inflammatory cell count induce sputum . Breath-prints analyze discriminant analysis principal component reduction , result cross-validated accuracy value . Receiver Operating Characteristics ( ROC ) calculate . Legal ethical aspects The study conduct accordance Declaration Helsinki principle ( 18th Word Medical Assembly , 1964 ) approve Clinical Research Ethics Committee ( approval number : IIBSP/10/122/1161 ) institution . The participant provide write informed consent participate study personal identification data anonymized .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Adults persistent asthma , define per Global INitiative Asthma Management ( GINA ) criterion , specifically positive bronchodilator test , daily peak expiratory flow ( PEF ) variability great 20 % , positive methacholine challenge test document case history . Subjects consecutively enrolled outpatient visit specialize Asthma Unit locate tertiary University Hospital . Subjects exclude respiratory tract infection asthma exacerbation within 30 day prior inclusion receive oral steroid immunosuppressive treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>asthma ; inflammation ; electronic nose</keyword>
</DOC>